This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma…
Read More
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
March 4 (Reuters) – Moderna shares rose 10% on Wednesday after the company settled a long-running legal battle over the…
Read More
Moderna stock surges as FDA reverses course, agrees to review new flu shot
Moderna (MRNA) stock jumped more than 6% on Wednesday after the US Food and Drug Administration agreed to review the…
Read More
